Innate Pharma annual total assets
2017
2018
2019
2020
2021
2022
2023
2024
2025
Innate Pharma Total Assets Growth & History (IPH)
Innate Pharma's total assets was €62.7M for fiscal 2025.
View full Innate Pharma company overviewInnate Pharma annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €62.7M | −€48.3M | −43.53% |
| 2024 | 2024-12-31 | €111.1M | −€64.1M | −36.61% |
| 2023 | 2023-12-31 | €175.2M | −€32.7M | −15.72% |
| 2022 | 2022-12-31 | €207.9M | −€59.6M | −22.29% |
| 2021 | 2021-12-31 | €267.5M | −€39.9M | −12.99% |
| 2020 | 2020-12-31 | €307.4M | −€93.9M | −23.40% |
| 2019 | 2019-12-31 | €401.4M | −€49.9M | −11.05% |
| 2018 | 2018-12-31 | €451.2M | €196.2M | +76.93% |
| 2017 | 2017-12-31 | €255.0M | — | — |
Innate Pharma quarterly total assets
Q4.20
Q2.21
Q4.21
Q2.22
Q4.22
Q2.23
Q4.23
Q2.24
Q4.24
Q2.25
Q4.25
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | €62.7M | −€48.3M | −43.53% |
| Q2 2025 | 2025-06-30 | €92.9M | −€58.6M | −38.65% |
| Q4 2024 | 2024-12-31 | €111.1M | −€64.1M | −36.61% |
| Q2 2024 | 2024-06-30 | €151.5M | −€47.6M | −23.89% |
| Q4 2023 | 2023-12-31 | €175.2M | −€24.1M | −12.10% |
| Q2 2023 | 2023-06-30 | €199.0M | −€81.4M | −29.02% |
| Q4 2022 | 2022-12-31 | €199.3M | −€68.2M | −25.50% |
| Q2 2022 | 2022-06-30 | €280.4M | €14.2M | +5.34% |
| Q4 2021 | 2021-12-31 | €267.5M | −€39.9M | −12.99% |
| Q2 2021 | 2021-06-30 | €266.2M | — | — |
| Q4 2020 | 2020-12-31 | €307.4M | — | — |
Innate Pharma total assets trends
Over the last five fiscal years, Innate Pharma's total assets decreased from €307.4M to €62.7M, a change of −€244.7M. The latest reported quarter, Q4 2025, shows €62.7M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Innate Pharma source filings ↗